Skip to main content

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses

References

  1. He, Y., Lu, H., Siddiqui, P., Zhou, Y., and Jiang, S. (2005). Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol 174, 4908–4915.

    CAS  Article  PubMed  Google Scholar 

  2. Hu, B., Ge, X., Wang, L.F., and Shi, Z. (2015). Bat origin of human coronaviruses. Virol J 12, 221.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jiang, S., He, Y., and Liu, S. (2005). SARS vaccine development. Emerg Infect Dis 11, 1016–1020.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., Somasundaran, M., Sullivan, J.L., Luzuriaga, K., Greenough, T.C., Choe, H., and Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454.

    CAS  Article  PubMed  Google Scholar 

  5. Wong, S.K., Li, W., Moore, M.J., Choe, H., and Farzan, M. (2004). A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 279, 3197–3201.

    CAS  Article  PubMed  Google Scholar 

  6. Zeng, L.P., Gao, Y.T., Ge, X.Y., Zhang, Q., Peng, C., Yang, X.L., Tan, B., Chen, J., Chmura, A.A., Daszak, P., and Shi, Z.L. (2016). Bat severe acute respiratory syndrome-like coronavirus WIV1 encodes an extra accessory protein, ORFX, involved in modulation of the host immune response. J Virol 90, 6573–6582.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. Zhou, P., Han, Z., Wang, L.F., and Shi, Z. (2013). Identification of immunogenic determinants of the spike protein of SARS-like coronavirus. Virol Sin 28, 92–96.

    CAS  Article  PubMed  Google Scholar 

  8. Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L.E., Prabakaran, P., Rockx, B., Sidorov, I.A., Corti, D., Vogel, L., Feng, Y., Kim, J.O., Wang, L.F., Baric, R., Lanzavecchia, A., Curtis, K.M., Nabel, G.J., Subbarao, K., Jiang, S., and Dimitrov, D.S. (2007). Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci USA 104, 12123–12128.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81290341, 31621061 to Zheng-Li Shi), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB0301 to Zheng-Li Shi), National Institute of Allergy and Infectious Diseases of National Institutes of Health grant (R01AI110964 to Zheng-Li Shi), the National Key Research and Development Program of China (2016YFC1201000 to Shibo Jiang) and NIH grant (R01AI098775 to Shibo Jiang and Lanying Du).

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Lanying Du or Zheng-Li Shi.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zeng, LP., Ge, XY., Peng, C. et al. Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses. Sci. China Life Sci. 60, 1399–1402 (2017). https://doi.org/10.1007/s11427-017-9189-3

Download citation